default author photo

Eva Muñoz-Couselo

Vall d’Hebron Institute of Oncology (VHIO)

SCHOLARLY PAPERS

4

DOWNLOADS

265

TOTAL CITATIONS

0

Scholarly Papers (4)

Actions:
Email selected abstracts
1.

Cross-Method Comparison for Braf P.V600 Mutation Cfdna Testing in Melanoma: Brafi Study

Downloads 117 (608,822)

Cross-Method Comparison for Braf P.V600 Mutation Cfdna Testing in Melanoma: Brafi Study

Number of pages: 22 Posted: 28 Feb 2025
Clara Mayo de las Casas, Eloisa Jantus-Lewintre, Sebastian Ortiz Reina, Ana Drozdowskyj, Pablo Cerezuela, Jose Luis Manzano, Pablo Ayala de Miguel, Ana M. Arance, Miguel Angel Berciano Guerrero, Almudena García Castaño, Teresa Puertolas, Guillermo Crespo, Maria Quindos-Varela, Juan Francisco Rodriguez-Moreno, Alfonso Berrocal Jaime, Eva Muñoz-Couselo, Enrique Espinosa, Joselyn Valarezo, Susana Muñoz, Silvia Calabuig-Fariñas, Miguel A. Molina-Vila, Rafael Rosell, Joan Anton Puig-Butille and Maria Gonzalez-Cao
affiliation not provided to SSRN, affiliation not provided to SSRN, Universidad de Cartagena, affiliation not provided to SSRN, affiliation not provided to SSRN, Autonomous University of Barcelona - Hospital Germans Trias i Pujol, affiliation not provided to SSRN, Hospital of Barcelona, Hospital Regional Universitario de Málaga, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Vall d’Hebron Institute of Oncology (VHIO), Hospital Universitario La Paz, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Quirón-Dexeus University Institute - Pangaea Oncology, affiliation not provided to SSRN, Universidad de Barcelona - Hospital Clínic Barcelona and affiliation not provided to SSRN
Downloads 86 (773,441)

Abstract:

Loading...

Melanoma, BRAF mutation, Liquid Biopsy

Cross-Method Comparison for Braf P.V600 Mutation Cfdna Testing in Melanoma: Brafi Study

Number of pages: 40 Posted: 06 Jun 2025
Clara Mayo de las Casas, Eloisa Jantus-Lewintre, Sebastian Ortiz Reina, Ana Drozdowskyj, Pablo Cerezuela, Jose Luis Manzano, Pablo Ayala de Miguel, Ana M. Arance, Miguel Angel Berciano Guerrero, Almudena García Castaño, Teresa Puertolas, Guillermo Crespo, Maria Quindos-Varela, Juan Francisco Rodriguez-Moreno, Alfonso Berrocal Jaime, Eva Muñoz-Couselo, Enrique Espinosa, Joselyn Valarezo, Susana Muñoz, Silvia Calabuig-Fariñas, Miguel A. Molina-Vila, Rafael Rosell, Joan Anton Puig-Butille and Maria Gonzalez-Cao
affiliation not provided to SSRN, affiliation not provided to SSRN, Universidad de Cartagena, affiliation not provided to SSRN, affiliation not provided to SSRN, Autonomous University of Barcelona - Hospital Germans Trias i Pujol, affiliation not provided to SSRN, Hospital of Barcelona, Hospital Regional Universitario de Málaga, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Vall d’Hebron Institute of Oncology (VHIO), Hospital Universitario La Paz, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Quirón-Dexeus University Institute - Pangaea Oncology, affiliation not provided to SSRN, Universidad de Barcelona - Hospital Clínic Barcelona and affiliation not provided to SSRN
Downloads 31 (1,341,098)

Abstract:

Loading...

Melanoma, BRAF mutation, liquid biopsy

2.

Recommendations for the Management of Cutaneous Squamous Cell Carcinoma: A Systematic Multidisciplinary Delphi Consensus Approach

Number of pages: 41 Posted: 24 Aug 2024
Eva Muñoz-Couselo, Javier Cañueto, Vanessa Jerviz Guía, Ana María López López, Josep Oriol Bermejo Segú, Almudena García Castaño, Susana Puig, Onofre Sanmartín Jiménez, Ainara Soria Rivas, Paula Gratal, María Teresa Pardo, Álvaro Rogado and Alfonso Berrocal Jaime
Vall d’Hebron Institute of Oncology (VHIO), affiliation not provided to SSRN, affiliation not provided to SSRN, - Hospital General Universitario Gregorio Marañón, affiliation not provided to SSRN, affiliation not provided to SSRN, Universidad de Barcelona - Hospital Clínic Barcelona, affiliation not provided to SSRN, Universidad de Alcalá - Hospital Universitario Ramón y Cajal, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 79 (809,932)

Abstract:

Loading...

Squamous cell carcinoma, consensus, Delphi, Spain

3.

A Pan-Cancer Clinical Platform to Predict Immunotherapy Outcomes and Prioritize Immuno-Oncology Combinations in Early-Phase Trials

Number of pages: 34 Posted: 17 Feb 2023
Alberto Hernando, Maria Vila-Casadesús, Yacine Bareche, Alberto Gonzalez-Medina, Francesco Mancuso, Deborah Lo Giacco, Agatha Martin, Omar Saavedra, Irene Brana, Maria Vieito, Roberta Fasani, John Stagg, Farnoosh Abbas-Aghababazadeh, Benjamin Haibe-Kains, Roger Berche, Nadia Saoudi Gonzalez, Claudia Valverde, Eva Muñoz-Couselo, Cristina Suarez, Marc Diez, Maria Elena Elez, Jaume Capdevila, Ana Oaknin, Cristina Saura, Teresa Macarulla, Joan Carles Galceran, Enriqueta Felip, Rodrigo Dienstmann, Philippe L. Bedard, Paolo Nuciforo, Joan Seoane, Josep Tabernero, Josep Tabernero, Elena Garralda and Ana Vivancos
Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), University of Montreal - Faculté de Pharmacie, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Université de Montréal - Faculty of Pharmacy, University Health Network - Princess Margaret Bioinformatics and Computational Genomics Laboratory, University Health Network - Princess Margaret Bioinformatics and Computational Genomics Laboratory, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO)Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO) and Vall d’Hebron Institute of Oncology (VHIO)
Downloads 43 (1,145,425)

Abstract:

Loading...

4.

Quality and safety of research biopsies in oncology clinical trial

Number of pages: 20 Posted: 28 Apr 2026
Paolo Nuciforo, Fiorella Ruiz-Pace, José Jimenez, Raquel Comas Navarro, Roberta Fasani, Cristina Viaplana, Cesar Sevillano, Paola Martinez, Xavier Serres-Créixams, Nuria Roson, Cristina Saura, Maria Elena Elez, Ana Oaknin, Irene Brana, Eva Muñoz-Couselo, Teresa Macarulla, Joan Carles Galceran, Josep Tabernero, Josep Tabernero, Enriqueta Felip, Elena Garralda and Rodrigo Dienstmann
Vall d’Hebron Institute of Oncology (VHIO), affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Vall d’Hebron Institute of Oncology (VHIO), affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO)Hospital Vall d’Hebron, Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO) and Vall d’Hebron Institute of Oncology (VHIO)
Downloads 26 (1,372,601)

Abstract:

Loading...

research biopsies, safety, tumour content, ethics, precision oncology, clinical trials.